These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 30471388)

  • 21. An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative.
    Samtani MN; Farnum M; Lobanov V; Yang E; Raghavan N; Dibernardo A; Narayan V;
    J Clin Pharmacol; 2012 May; 52(5):629-44. PubMed ID: 21659625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating long-term multivariate progression from short-term data.
    Donohue MC; Jacqmin-Gadda H; Le Goff M; Thomas RG; Raman R; Gamst AC; Beckett LA; Jack CR; Weiner MW; Dartigues JF; Aisen PS;
    Alzheimers Dement; 2014 Oct; 10(5 Suppl):S400-10. PubMed ID: 24656849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
    Kang JH; Korecka M; Figurski MJ; Toledo JB; Blennow K; Zetterberg H; Waligorska T; Brylska M; Fields L; Shah N; Soares H; Dean RA; Vanderstichele H; Petersen RC; Aisen PS; Saykin AJ; Weiner MW; Trojanowski JQ; Shaw LM;
    Alzheimers Dement; 2015 Jul; 11(7):772-91. PubMed ID: 26194312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canonical feature selection for joint regression and multi-class identification in Alzheimer's disease diagnosis.
    Zhu X; Suk HI; Lee SW; Shen D
    Brain Imaging Behav; 2016 Sep; 10(3):818-28. PubMed ID: 26254746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic prediction of Alzheimer's disease progression using features of multiple longitudinal outcomes and time-to-event data.
    Li K; Luo S
    Stat Med; 2019 Oct; 38(24):4804-4818. PubMed ID: 31386218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstructing subject-specific effect maps.
    Konukoglu E; Glocker B;
    Neuroimage; 2018 Nov; 181():521-538. PubMed ID: 30048747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
    Podhorna J; Krahnke T; Shear M; Harrison JE;
    Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.
    Steenland K; Zhao L; John SE; Goldstein FC; Levey A; Alvaro A;
    J Alzheimers Dis; 2018; 63(4):1383-1393. PubMed ID: 29843232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantifying the pathophysiological timeline of Alzheimer's disease.
    Yang E; Farnum M; Lobanov V; Schultz T; Verbeeck R; Raghavan N; Samtani MN; Novak G; Narayan V; DiBernardo A;
    J Alzheimers Dis; 2011; 26(4):745-53. PubMed ID: 21694449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage.
    Vos SJ; Verhey F; Frölich L; Kornhuber J; Wiltfang J; Maier W; Peters O; Rüther E; Nobili F; Morbelli S; Frisoni GB; Drzezga A; Didic M; van Berckel BN; Simmons A; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Muscio C; Herukka SK; Salmon E; Bastin C; Wallin A; Nordlund A; de Mendonça A; Silva D; Santana I; Lemos R; Engelborghs S; Van der Mussele S; ; Freund-Levi Y; Wallin ÅK; Hampel H; van der Flier W; Scheltens P; Visser PJ
    Brain; 2015 May; 138(Pt 5):1327-38. PubMed ID: 25693589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Associations of event-related brain potentials and Alzheimer's disease severity: A longitudinal study.
    Fruehwirt W; Dorffner G; Roberts S; Gerstgrasser M; Grossegger D; Schmidt R; Dal-Bianco P; Ransmayr G; Garn H; Waser M; Benke T
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():31-38. PubMed ID: 30582941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Progression From Mild Cognitive Impairment to Alzheimer's Disease Using Autoregressive Modelling of Longitudinal and Multimodal Biomarkers.
    Minhas S; Khanum A; Riaz F; Khan SA; Alvi A
    IEEE J Biomed Health Inform; 2018 May; 22(3):818-825. PubMed ID: 28534796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling disease progression via multi-task learning.
    Zhou J; Liu J; Narayan VA; Ye J;
    Neuroimage; 2013 Sep; 78():233-48. PubMed ID: 23583359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.
    Galluzzi S; Marizzoni M; Babiloni C; Albani D; Antelmi L; Bagnoli C; Bartres-Faz D; Cordone S; Didic M; Farotti L; Fiedler U; Forloni G; Girtler N; Hensch T; Jovicich J; Leeuwis A; Marra C; Molinuevo JL; Nobili F; Pariente J; Parnetti L; Payoux P; Del Percio C; Ranjeva JP; Rolandi E; Rossini PM; Schönknecht P; Soricelli A; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    J Intern Med; 2016 Jun; 279(6):576-91. PubMed ID: 26940242
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic predictions in Bayesian functional joint models for longitudinal and time-to-event data: An application to Alzheimer's disease.
    Li K; Luo S
    Stat Methods Med Res; 2019 Feb; 28(2):327-342. PubMed ID: 28750578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Novel Grading Biomarker for the Prediction of Conversion From Mild Cognitive Impairment to Alzheimer's Disease.
    Tong T; Gao Q; Guerrero R; Ledig C; Chen L; Rueckert D; Initiative ADN
    IEEE Trans Biomed Eng; 2017 Jan; 64(1):155-165. PubMed ID: 27046891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical Disease Progression Modeling in Alzheimer Disease.
    Raket LL
    Front Big Data; 2020; 3():24. PubMed ID: 33693397
    [No Abstract]   [Full Text] [Related]  

  • 40. Analysis of longitudinal diffusion-weighted images in healthy and pathological aging: An ADNI study.
    Kruggel F; Masaki F; Solodkin A;
    J Neurosci Methods; 2017 Feb; 278():101-115. PubMed ID: 28057473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.